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Available online 6 January 2016AbstractTwo simple, sensitive and validated spectrophotometric methods have been described for the assay of nicorandil in drug for-
mulations. Method A is based on the determination of nicorandil by using leuco crystal violet (LCV). Nicorandil liberates nitrite on
reaction with Zn and NH4Cl, which reacts with acidified KI to liberate iodine, which reacts with LCV to form crystal violet (CV).
The calibration graphs were linear over the concentration ranges 0.1 mgmL1e2.0 mgmL1& 0.2 mgmL1e4.0 mgmL1
respectively. The absorbance of which is measured at 592 nm. Another method is based on diazotization of p-amino acetanilide by
liberated nitrite followed by coupling with orcinol, which shows maximum absorbance at 458 nm. The optimum conditions and
other analytical parameters were evaluated. The proposed methods have been applied successfully to the analysis of nicorandil in
pure form and its dosage forms and no interference was observed from common excipients present in pharmaceutical formula-
tions.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of University of Kerbala. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Nicorandil is a cardiovascular drug which posses
properties like nitrate and ATP- sensitive potassium
channel activating property. It is chemically known as
N-[2-(nitroxy) ethyl] 3-pyridine carboxamide. It is se-
lective for vascular potassium channels. It has no sig-
nificant action on cardiac contractility and conduction.
Thus is a novel drug for treatment of angina pectoris [1].* Corresponding author.
E-mail address: kanchan.chemistry@gmail.com (K. Upadhyay).
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2405-609X/© 2015 The Authors. Production and hosting by Elsevier B.V. o
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/Further many studies have suggested that the drug
possess similar safety and efficacy as the other drugs
used for angina but efficacy increase after a year on
continued treatment [2,3]. The drug has also now been
evaluated in combination with other drugs like
Lamotrigine [4]. Primary oxidation metabolites of
nicorandil are nicorandil-N-oxide and hydroxyl nicor-
andil. On denitration nicorandil gives N-[2-hydroxy
ethyl] nicotinamide, which further is transformed to
nicotinamide, nicotine and N-methyl nicotinamide.
The denitration occurs primarily in the liver.
Nicorandil is officially listed in Martindale: The
Extra Pharmcopeia [5]. The literature revealed manyn behalf of University of Kerbala. This is an open access article under
4.0/).
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biological fluids and drug formulations. The methods
include high performance liquid chromatography
[6e14], high performance thin layer chromatography
[15], gas chromatography coupled with mass spec-
trometry [16] and polarography [17].
HPLC, GC, and HPTLC methods widely used for
pharmaceutical analysis are accurate and precise with
good reproducibility but the cost of analysis is quite
high owing to expensive instrumentation, reagent and
expertise. Hence it is worthwhile to develop simpler
and cost effective method for simultaneous estimation
of drug for routine analysis of formulation. Spectro-
photometric method fulfils such requirements [18e23].
The literature reveals that only few spectrophoto-
metric methods have been developed for determination
of nicorandil in drug formulations and biological fluids
[24e28].
The main purpose of the present study is to develop
spectrometric analysis method for analytical method
for analysis of nicrodil. In the proposed methods
method A is based on the oxidizing nature of nicor-
andil for oxidation of potassium iodide to liberate
iodine which on reaction with leuco crystal violet
(LCV) produces crystal violet (CV) and method B is
based on denitration of nicorandil, diazotization of p-
amino acetanilide by liberated nitrite and its coupling
with orcinol.
2. Materials and methods
2.1. Apparatus
All the absorbance measurements were made by a
Systronics spectrophotometer (Model 166) and a
Systronics digital pH meter (Model-335) was used for
the pH measurements.
2.2. Reagents and solutions
All the reagents used were of analytical reagent
grade and double distilled water was used throughout
the experiment.
Nicorandil Stock Solution: Reference standard
sample of nicorandil was purchased from Zydus
medica, Ahmadabad, India and was used as received.
The commercial dosage forms of nicorandil such as
Nikoran (Torrent Pharmaceutical, Ahmadabad, India),
Korandil (Sun Pharm. Industries Ltd. Mumbai, India)
and Zynicor (Zydus Medica, Ahmadabad, India) were
purchased from the local market. The preparation of
the standard stock solution of nicorandil containing1000 mgmL1was done by dissolving 100 mg of nic-
orandil in 100 mL double distilled water.
Leuco Crystal Violet(LCV)[Eastman Kodak co.]:
250 mg of LCV was dissolved in 200 mL distilled
water containing 3 mL 85% phosphoric acid (Merck,
India) and the volume was made up to 1 L with
distilled water and was stored in amber colored bottle
away from sunlight.
Potassium iodide (Merck, India): 6  102 M
Aqueous solution was prepared in distilled water.
Ammonium chloride (Merck, India): 0.2 M
aqueous solution was prepared in distilled water.
p -Amino acetanilide: 0.1% (w/v) aqueous solution
was prepared in distilled water.
Orcinol: 1% (w/v) Aqueous solution was prepared
in distilled water.
2.3. Procedure
2.3.1. Preparation of calibration graph
2.3.1.1. Method A. Different aliquot containing 0.1 to
2.0 mgmL1of nicorandil were accurately measured and
transferred into a series of 25 mL standard flask and the vol-
umewas adjusted to 5 mL by adding double distilled water. To
each flask 4.0 mL of 2  102 M NH4Cl and 0.2 gm zinc
powder was added and left for 3 min and the content was
filtered. To the flask 1 mL of 1 M HCl, 1 mL of LCVand 1 mL
of potassium iodide was added. The content was mixed well
and the flasks were let to stand for 10 min with occasional
shaking then pH of each mixture was adjusted with sodium
hydroxide solution. The volume was diluted to the mark with
water, mixed well and absorbance was measured at 592 nm
against reagent blank.
2.3.1.2. Method B. Varying aliquots of standard nicorandil
solution containing 0.2e4.0 mgmL1 nicorandil were accu-
rately measured and transferred into a series of 25 mL
calibrated flasks and the total volume was adjusted to 5.0 mL
with double distilled water. To each flask 4.0 mL of
2  102 M NH4Cl and 0.2 gm zinc powder were added and
left for 3 min and filtered. To the flask 1 mL of p-amino-
acetanilide and 1.5 mL of 0.05 M HCl is added successively
and allowed to stand for 5 min in an ice bath with occasional
shaking then 0.5 mL of orcinol solution was added and the
volume was adjusted up to the mark with distilled water. The
absorbance was measured at 458 nm against the reagent
blank.
2.4. Quatitation of nicorandil in pharmaceutical
formulations
Twenty tablets were weighed and grounded, and
then the powder equivalent to 100 mg nicorandil was
Scheme 1. Color reaction for method A.
Fig. 1. Graph for absorption maxima (lmax) (a) for method B (b) for
method A.
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residue was washed with dichloromethane for com-
plete recovery of the drug. The filtrate was evaporated
to dryness under vacuum and the left drug was taken
up with doubly distilled water and transferred to a
100 mL standard flask and completed to volume with
doubly distilled water. A convenient aliquot of filtrate
was taken for analysis following the procedures
described earlier.
3. Results
Nicorandil contains nitroxy ethyl group which gives
carbonyl derivative of nicorandil and nitrite ion on
treatment with Zn and ammonium chloride. Zinc is one
of the most frequently used reducing agent for
4 K. Upadhyay et al. / Karbala International Journal of Modern Science 2 (2016) 1e9reduction of nitrate into nitrite, while ammonium
chloride is used to assist the reduction process. In
method (A) the nitrite produced in this manner reacts
with acidified potassium iodide to liberate iodine. The
liberated iodine oxidizes leucocrystal violet to crystal
violet dye (Scheme 1) which gives maximum absor-
bance at 592 nm (Fig. 1) and in the method (B) nitrite
diazotized p-amino acetanilide in presence of HCl and
subsequently coupling with orcinol gives a colored
product (Scheme 2) which gives maximum absorbance
at 458 nm (Fig. 1).
3.1. Optimization of reaction variables
3.1.1. Effect of varying reaction conditions
Various parameters responsible for the formation of
the colored product were studied and optimized by
conducting a series of experiments.
3.1.2. Effect of zinc
To determine the effect of zinc on the reduction of
nicorandil to yield nitrite ion, a known amount of
nicorandil (0.5 mg) was treated with different amount
of zinc dust (0.01e0.4 gm) in presence of 2  102 M
NH4Cl. It was observed that maximum intensity was
obtained with 0.2 gm of zinc, which remains constant
up to 0.4 gm. Therefore, 0.2 gm of zinc dust was
selected as an optimum quantity for the reduction
process (Fig. 2).
3.1.3. Effect of NH4Cl concentration on the reduction
process
The effect of ammonium chloride on the reduction
process was examined in the range of
6.0  104e2.5  102 M and keeping the constant
amounts of nicorandil (0.5 mg) and zinc dust (0.2 gm).
It was found that the absorbance increased with
increasing concentration of NH4Cl and maximum
absorbance was obtained with 1.5  102 M NH4Cl,
which remained constant up to 2.5  102 M. There-
fore, 2.0  102 M NH4Cl was selected for further
investigation (Fig. 3).
3.1.4. Effect of time on the reduction process
The effect of time on the reduction process was
studied by treating 0.5 mg nicorandil with 0.2 gm of
zinc dust and 2  102 M NH4Cl. A constant absor-
bance was obtained after 3 min. Hence, a time of 3 min
was selected as an optimum value for the reduction
process (Fig. 4).3.1.5. Effect of other reagent concentrations
For method A the effect of potassium iodide and
LCV was studied by treating 0.5 mgm reduced nic-
orandil with various amounts of these reagents. A
constant absorbance was obtained by addition of
5  102 mol L1 of potassium iodide solution and
remained constant up to 1  101 mol L1 them it's
decreased. Hence, 6  102 mol L1 was selected
as an optimized concentration for the reaction
(Fig. 5).
For LCV a constant absorbance was obtained by
addition of 0.5 mL and remained constant up to
2.0 mL. Hence, 1 mL was selected for further studies
(Fig. 6).
For Method B the effect of p-amino acetanilide and
orcinol was studied. A constant absorbance was ob-
tained by addition of 0.6e2.5 mL of 0.1% p-amino
acetanilide and 0.3e1.5 mL of 1% orcinol.
Hence 1 mL of p-amino acetanilide (Fig. 6) and
0.5 mL of orcinol were selected for further studies
(Fig. 6).
3.1.6. Effect of reaction time
To optimize the reaction time for the color devel-
opment, the 0.5 mg drug was treated with 0.2 gm zinc
dust and 2  102 M NH4Cl and left still for 3 min
and then filtered. To the filtrate containing nitrite ions,
1 mL of 1 M HCl, and 1 mL of LCV and 1 mL of
potassium iodide was added and the mixture was kept
for different time intervals 3e15 min. The maximum
intensity was obtained at 8 min and remained constant
up to 48 h. Therefore, a time of 10 min was selected
as an optimum time for the reaction (Method A). For
method B to determine the effect of time 1 mL of p-
aminoacetanilide and 1.5 mL of 0.05 M HCl were
added successively to the filtrate and allowed to stand
for different time intervals 0.5e10 min in an ice bath
with occasional shaking then 0.5 mL of orcinol so-
lution was added and diluted with distilled water. The
maximum intensity was obtained after 3 min and
remained constant up to 24 h. Therefore, a time of
5 min was selected as an optimum time for
diazotization.
3.1.7. Effect of pH
The influence of HCl concentration on the absor-
bance of the colored product was studied in the range
of 0.5e2 M for method A and
2.5  102e6  102 M for method B. The intensity
increases with increasing HCl concentration and a
constant absorbance was obtained in the concentration
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selected for studies, for method B constant absorbance
was obtained in the concentration range
3.5  102e6  102 M, hence 5  102 M was
selected for studies (Fig. 7).
In method A pH 2-3 was required for liberation of I2
and it gives blue color with LCV at pH 4 - 4.5. After
pH 5 the solution becomes turbid. Initial pH wasmaintained by 1 mL of 1 M HCl, later on the pH was
adjusted up to 4 by using 0.1 M NaOH solution
(Fig. 8).
In method B pH 2-3 was required for diazotization of
p-aminoacetanilide, which on coupling with orcinol
gives orange yellow color at pH 10-11. Initial pH was
maintained by 1 mL of 5 102 M HCl, later on the pH
was adjusted by using 0.1 M NaOH solution (Fig. 9).
Fig. 2. Effect of amount of Zn on denitration of nicorandil.
Fig. 3. Effect of ammonium chloride concentration on reduction.
Fig. 4. Effect of time on (a) reduction of nicorandil (b) color
development for method A (c) diazotization coupling reaction
Fig. 5. Effect of KI concentration.
Fig. 6. (a) Effect of LCV on colored reaction (b) Effect of p-ami-
noacetanilide (c) Effect of orcinol.
Fig. 7. Effect of HCl concentration on diazotization coupling reac-
tion for Method A.
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Fig. 8. Effect of pH on (a) color development of CV (b) color
development of coupled dye
Fig. 9. Calibration graph (a) for method A (b) for method B.
Table 1
Analytical and regression parameters for spectrophotometric
determination.
Parameters Results (n ¼ 6)
Method A Method B
lmax, (nm) 592 458
Beer's law limits (mg mL1) 0.1e2.0 0.2e3.5
Molar absorptivity (L mol1 m1) 1.59  105 0.953  105
Sandell's sensitivity (mg cm2) 0.00132 0.00221
Limit of detection (mg mL1) 0.038 0.064
Limit of quantification (mg mL1) 0.117 0.192
Regression equation (Y ¼ bX*þa)
Slope(b) 0.766 0.467
Standard deviation of slope (Sb) 0.020 0.055
Intercept(a) 0.004 0.003
Standard deviation of intercept (Sa) 0.003 0.007
Variance (Sa
2) 9  106 4.9  105
Correlation coefficient 0.998 0.999
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4.1. Method validation
The proposed methods have been validated for
linearity, precision, accuracy, recovery, limits of
detection and quatitation. The absorbance vs. concen-
tration was plotted and a linear correlation was found
(Fig. 9). Beer's law was followed for the concentration
range 0.1e2.0 mgmL1 (method A) and
0.2e3.5 mgmL1 (method B), the molar absorptivity
and Sandell's sensitivity given in Table 1. The limits of
detection, limit of quantification, regression equation,
and correlation coefficients calculated according to the
current ICH guidelines are presented in Table 1.
Accuracy was evaluated as percentage relative error
between the measured concentrations and takenconcentration for nicorandil. The precision of the
methods was calculated in terms of intermediate pre-
cision (intra-day and inter-day). Three different con-
centrations of nicorandil (within the working limits)
were analyzed in seven replicates during the same day
and five consecutive days. The SD and RSD values of
intra-day and inter-day studies showed that precision
was good (Tables 2 and 3).
The proposed methods are compared with the
literature method [19,28] and the students t-test and F-
test results shows the methods have good accuracy
(Table 4).
The specificity of the proposed methods was
examined by taking 2.0 mgmL1nicorandil. To check
the specificity of the proposed method, synthetic
mixture containing nicorandil with excipients
commonly used in solid dosage forms contains lactose
(75 mg), starch (100 mg), talc (100 mg) and magne-
sium stearate (10 mg). A portion of synthetic mixture
equivalent to 5 mg nicorandil was transferred to 50 mL
conical flask and treated as described in “Quatitation of
nicorandil in pharmaceutical formulations” [28].
5. Conclusion
The method is very simple, rapid, sensitive and
reproducible. The method does not suffer from insta-
bility of colors. The validation experiments provided
proof that the proposed method is linear in the pro-
posed working range as well as accurate, precise,
specific and reproducible. No interference was
observed from the denitrated nicorandil and common
excipients. The method has been successfully applied
in the determination of nicorandil in formulations and
biological samples.
Table 2
Inter-day and Intra-day precision and accuracy studies for method A.
Nicorandil
taken (mgL1)
Intra-day (n ¼ 7) Inter-day (n ¼ 5)
Found Precisiona Accuracyb Found Precisiona Accuracyb
0.5 0.51 ± 0.015 5.4 1.71 0.52 ± 0.015 4.24 3.2
1 1.02 ± 0.031 1.8 2.14 1.01 ± 0.032 1.5 1.4
2 2.05 ± 0.031 1.5 2.5 2.06 ± 0.032 1.6 3.0
a Relative standard deviation (%).
b Bias%: (found-taken/taken) x 100.
Table 3
Inter-day and Intra-day precision and accuracy studies for method B.
Nicorandil
taken (mgL1)
Intra-day (n ¼ 7) Inter-day (n ¼ 5)
Foundb Precisiona Accuracyc Found Precisiona Accuracyb
1 1.02 ± 0.027 1.48 2.14 1.01 ± 0.022 1.5 1.4
2 2.04 ± 0.018 1.51 2.13 2.05 ± 0.015 1.6 2.6
3 3.04 ± 0.031 1.01 1.42 3.05 ± 0.033 1.1 1.7
a Mean value of five determinations.
b Relative standard deviation (%).
c Bias%: (found-taken/taken)  100.
Table 4
Results of assay of tablets by the proposed methods and statistical
evaluation.
Tablet
brand
name
Nominal
amount
(mg/Tab)
Literature
method
Proposed
method A
Proposed
method B
Nikoran 100 97.9 ± 0.23 98.15 ± 0.11 98.3 ± 0.20
t ¼ 1.522 t ¼ 2.37
F ¼ 4.37 F ¼ 1.322
Korandil 100 98.1 ± 0.26 98.6 ± 0.28 98.8 ± 0.32
t ¼ 2.369 t ¼ 2.38
F ¼ 1.16 F ¼ 1.514
Zynicor 100 98.8 ± 0.21 98.96 ± 0.26 99.2 ± 0.37
t ¼ 1.076 t ¼ 2.47
F ¼ 1.53 F ¼ 3.104
Mean value of five determinations.
Tabulated t-value at the 95% confidence level is 2.78; Tabulated F-
value at the 95% confidence level is 6.39.
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